Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Drug-Related Side Effects and Adverse Reactions × Fibroblast Growth Factor 7 × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 2 Sarcoma 1 Other hematologic neoplasm 1 Other 1 Lymphoid 1

Conditions

Mucositis 4 Xerostomia 1 Stomatitis 1 Oral Ulcer 1 Neoplasms 1 Multiple Myeloma 1 Leukemia 1 Laryngeal Diseases 1 Head and Neck Neoplasms 1 Drug-Related Side Effects and Adverse Reactions 1 Carcinoma, Squamous Cell 1

Interventions

Melphalan 1 Fibroblast Growth Factor 7 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00482846 2014-04-15

Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma

Barbara Ann Karmanos Cancer Institute

Phase 1 Completed

OtherPlasma cell

Multiple Myeloma, Mucositis, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon ⚡